Jpmorgan Chase & Co »

Indivior Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 270k 41.26
2026-03-31 $16M 540k 28.78

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Hanna Zanoni
Morgan Stanley
Two Seas Capital
Franklin Resources
Geode Capital Management
Madison Avenue Partners
Citadel Advisors
Mangrove Partners
Driehaus Capital Management
Millennium Management

View all funds holding Indivior Pharmaceuticals